Release Date: 13/12/17 18:38 Summary: Change of Director's Interest Notice - Amended Price Sensitive: No Download Document 697.43KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%